Vancomycin: Clinical Trials

8 trials for Vancomycin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 recruiting, 2 unknown, 1 not yet recruiting. 8 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable8Completed 3, Recruiting 2, Unknown 2, Not yet recruiting 1

Follow Vancomycin: new trials by email Literature Review of Vancomycin trials Research Report on Vancomycin

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
STOP-CDI: Efficacy of Fecal Microbiota Transplantation vs Fidaxomicin vs Vancomycin in Treating and Preventing Relapse of Clostridioides Difficile Infection
FMT (fecal microbiota transplantation), Fidaxomicin, Vancomycin (VAN) treatment - Clostridioides Difficile Infection, Clostridioides Difficile Infection Recurrence
Not applicableNot yet recruitingMedical University of Warsaw4242025-10-012025-08-13
Vancomycin Reduction Practices (VRP) in the NICU
External Facilitation - Antibiotic Stewardship, Neonatal Sepsis, Late-Onset
Not applicableRecruitingChildren's Hospital of Philadelphia132025-06-022026-09-24
Effect of Direct-from-blood Bacterial Testing on Antibiotic Administration and Clinical Outcomes
T2Bacteria® Panel (direct-from-blood testing), Usual Care - Bloodstream Infection, Sepsis Bacterial
Not applicableCompletedVanderbilt University Medical Center5002023-12-132026-02-27
First Time Right of Vancomycin
Vancomycin - Vancomycin, Pharmacokinetics
Not applicableUnknownErasmus Medical Center1342023-10-012023-07-27
Clinical Decision Support Tool for Vancomycin Dosing in Children
Computer Decision Support Tool Intervention Group, Matched Historical Controls - Gram-Positive Bacterial Infections, Vancomycin
Not applicableCompletedUniversity of Maryland, Baltimore752022-05-092025-05-14
Vancomycin Dose Adjustments Comparing Trough Levels to The AUC/MIC Method Using a Bayesian Approach in a Hospitalized Adult Population
Vancomycin dose adjustment using the Bayesian method, Vancomycin dose adjustment using the trough level method - Vancomycin, Adult
Not applicableCompletedCR-CSSS Champlain-Charles-Le Moyne452021-03-012021-09-10
Optimal Dosing of Vancomycin in an Adult Population of Hemato-oncology
Additional blood sample - Vancomycin, Hematologic Malignancies
Not applicableUnknownCiusss de L'Est de l'Île de Montréal402021-02-012021-02-17
Pediatric Antibiotic Dosing in Extracorporal Membrane Oxygenation (PADECMO)
Amoxicillin-clavulanate, Piperacillin-tazobactam, Meropenem - Pharmacokinetics, Amoxicillin-clavulanate
Not applicableRecruitingUniversity Hospital, Ghent3002016-08-192026-09-21

Narrower conditions

Sepsis (2)  ·  Clostridium Infections (1)  ·  Febrile Neutropenia (1)  ·  Gram-Positive Bacterial Infections (1)  ·  Hematologic Neoplasms (1)  ·  Neonatal Sepsis (1)  ·  Reinfection (1)

Broader conditions

Infections (4)  ·  Pathologic Processes (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Inflammation (3)  ·  Systemic Inflammatory Response Syndrome (3)  ·  Bacterial Infections (2)  ·  Bacterial Infections and Mycoses (2)  ·  Agranulocytosis (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Cytopenia (1)  ·  Disease Attributes (1)  ·  Gram-Positive Bacterial Infections (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Infant, Newborn, Diseases (1)

Interventions

Vancomycin (3)  ·  Amikacin (1)  ·  Amoxicillin-Potassium Clavulanate Combination (1)  ·  Blood Specimen Collection (1)  ·  Cefazolin (1)  ·  Ciprofloxacin (1)  ·  Fecal Microbiota Transplantation (1)  ·  Fidaxomicin (1)  ·  Meropenem (1)  ·  Piperacillin, Tazobactam Drug Combination (1)  ·  Standard of Care (1)  ·  Teicoplanin (1)  ·  Therapeutics (1)

Sponsors

CR-CSSS Champlain-Charles-Le Moyne (1)  ·  Children's Hospital of Philadelphia (1)  ·  Ciusss de L'Est de l'Île de Montréal (1)  ·  Erasmus Medical Center (1)  ·  Medical University of Warsaw (1)  ·  University Hospital, Ghent (1)  ·  University of Maryland, Baltimore (1)  ·  Vanderbilt University Medical Center (1)

Countries

United States (3)  ·  Canada (2)  ·  Belgium (1)

Top investigators

Annick de Jaeger, MD (1)  ·  Matthew Semler, MD, MSc (1)  ·  Sagori Mukhopadhyay, MD, MMSc (1)

Results publications

PMID 39800394

NIH funding

T32HD087969 (1)